Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Peptides ; 46: 83-93, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23742999

ABSTRACT

Progastrin (PG) is processed into a number of smaller peptides including amidated gastrin (Gamide), non-amidated glycine-extended gastrin (Ggly) and the C-terminal flanking peptide (CTFP). Several groups have reported that PG, Gamide and Ggly are biologically active in vitro and in vivo, and are involved in the development of gastrointestinal cancers. CTFP is bioactive in vitro but little is known of its effects in vivo. This study investigated the bioactivity of CTFP in vivo in normal tissues using gastrin deficient (GASKO) mice and in two mouse models of cancer (SCID mice bearing xenograft tumors expressing normal or knocked-down levels of gastrin and a mouse model of hepatic metastasis). As with Ggly, CTFP treatment stimulated colonic proliferation in GASKO mice compared to control. CTFP also significantly increased apoptosis in the gastric mucosa of male GASKO mice. CTFP did not appear to effect xenograft growth or the incidence of liver metastases. This is the first demonstration that CTFP has specific biological activity in vivo in the colon and stomach.


Subject(s)
Apoptosis , Cell Division/physiology , Gastric Mucosa/metabolism , Gastrins/metabolism , Protein Precursors/metabolism , Animals , Cell Line, Tumor , Cell Movement , Cell Proliferation , Female , Gastrins/deficiency , Gastrins/genetics , Heterografts , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/secondary , Male , Mice , Mice, Inbred CBA , Mice, Knockout , Mice, SCID , Neoplasm Invasiveness , Neoplasm Transplantation , Peptide Fragments/metabolism
2.
Biochem Biophys Res Commun ; 404(4): 1083-7, 2011 Jan 28.
Article in English | MEDLINE | ID: mdl-21195058

ABSTRACT

The gastrointestinal hormone gastrin is generated from an 80 amino acid precursor (progastrin) by cleavage after dibasic residues by prohormone convertase 1. Phosphorylation of Ser(75) has previously been suggested, on the basis of indirect evidence, to inhibit cleavage of progastrin after Arg(73)Arg(74). Gastrins bind two ferric ions with high affinity, and iron binding is essential for the biological activity of non-amidated gastrins in vitro and in vivo. This study directly investigated the effect of iron binding and of serine phosphorylation on the cleavage of synthetic progastrin-derived peptides. The affinity of synthetic progastrin(55-80) for ferric ions, and the rate of cleavage by prohormone convertase 1, were not affected by phosphorylation of Ser(75). In contrast, in the presence of ferric ions the rate of cleavage of both progastrin(55-80) and phosphoSer(75)progastrin(55-80) by prohormone convertase 1 was significantly reduced. Hence iron binding to progastrin may regulate processing and secretion in vivo, and regulation may be particularly important in diseases with altered iron homeostasis.


Subject(s)
Gastrins/metabolism , Iron/metabolism , Protein Precursors/metabolism , Amino Acid Sequence , Gastrins/chemistry , Humans , Iron/chemistry , Molecular Sequence Data , Phosphorylation , Phosphoserine/metabolism , Proprotein Convertase 1/metabolism , Protein Precursors/chemistry , Serine/metabolism , Trypsin/metabolism
3.
Regul Pept ; 165(2-3): 224-31, 2010 Dec 10.
Article in English | MEDLINE | ID: mdl-20727916

ABSTRACT

Progastrin is processed to a number of peptides including glycine-extended gastrin, amidated gastrin and the C-terminal flanking peptide (CTFP). Progastrin and gastrin-gly are pro-proliferative and anti-apoptotic in gastric and colorectal cancer cell lines. The CTFP is a major form of progastrin in the stomach and colon and stimulates proliferation. However the effect of CTFP on apoptosis has not been examined. Using the human gastric carcinoma cell line AGS we show that CTFP attenuates apoptosis through a PI3-kinase pathway by stimulating the phosphorylation of Akt leading to sustained increases in the concentrations of Bcl-xL and phosphorylated Bad protein and by reducing caspase 3 activity. The anti-apoptotic effect represents an important potential mechanism for the growth promoting action of CTFP.


Subject(s)
Apoptosis/drug effects , Gastrins/chemistry , Peptide Fragments/chemistry , Peptide Fragments/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Protein Precursors/chemistry , Signal Transduction/drug effects , Blotting, Western , Cell Line, Tumor , Cell Survival/drug effects , Flow Cytometry , Humans
4.
Am J Physiol Gastrointest Liver Physiol ; 299(1): G220-7, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20395538

ABSTRACT

Precursors of the peptide hormone gastrin stimulate proliferation in the colorectal mucosa and promote the development of colorectal carcinoma. Gastrins bind two ferric ions selectively and with high affinity, and the biological activity of glycine-extended gastrin (Ggly) in vitro is dependent on the presence of ferric ions. The aim of the present study was to determine whether or not iron is required for biological activity of progastrin and Ggly in vivo. Rats that had undergone a colostomy were infused with Ggly, and proliferation was measured in the defunctioned rectal mucosa. Proliferation was also measured in the colonic mucosa of hGAS and MTI-Ggly mice, which, by definition, overexpress progastrin and Ggly, respectively. The requirement for iron was assessed by thrice-weekly injection of the chelating agent desferrioxamine (DFO). The proliferation index in the defunctioned rectal mucosa was significantly increased in the Ggly-infused rats, and the increase was significantly reduced after treatment with DFO. Treatment with DFO significantly reduced the crypt height and proliferation index in the colonic mucosa of hGAS and MTI-Ggly mice but had no effect on the same variables in wild-type mice. These observations are consistent with the hypothesis that the biological activity of progastrin and Ggly in vivo is dependent on the presence of ferric ions and further suggest that chelating agents may block the stimulatory effects of gastrin precursors in the development of colorectal carcinoma.


Subject(s)
Cell Proliferation , Colon/drug effects , Deferoxamine/pharmacology , Gastrins/metabolism , Intestinal Mucosa/drug effects , Iron/metabolism , Protein Precursors/metabolism , Rectum/drug effects , Siderophores/pharmacology , Animals , Colon/metabolism , Colon/pathology , Colostomy , Deferoxamine/administration & dosage , Female , Gastrins/administration & dosage , Gastrins/blood , Gastrins/genetics , Humans , Infusion Pumps, Implantable , Injections, Intraperitoneal , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Male , Mice , Mice, Transgenic , Protein Precursors/administration & dosage , Protein Precursors/blood , Protein Precursors/genetics , Rats , Rats, Sprague-Dawley , Rectum/metabolism , Rectum/pathology , Siderophores/administration & dosage , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...